This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NUVA NuVasive (NUVA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About NuVasive Stock (NASDAQ:NUVA) 30 days 90 days 365 days Advanced Chart Get NuVasive alerts:Sign Up Key Stats Today's Range$39.75▼$39.7550-Day Range$38.12▼$40.6652-Week Range$35.17▼$49.53VolumeN/AAverage Volume1.16 million shsMarket Capitalization$2.08 billionP/E Ratio79.50Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.Read More… Receive NUVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuVasive and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVA Stock News HeadlinesGlobus Medical targets $2.8B-$2.9B revenue in 2025 with Nevro acquisition integrationFebruary 21, 2025 | msn.comGlobus Medical: Some Caution After Its Deal For NevroFebruary 16, 2025 | seekingalpha.comThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.May 5, 2025 | Stansberry Research (Ad)Globus acquisition of Nevro complicates story, says StifelFebruary 6, 2025 | markets.businessinsider.comBTIG maintains $91 target on Globus Medical stock post-acquisitionFebruary 6, 2025 | msn.comSMAIO Provides Update on Its Partnership With NuVasive and Confirms Its Strategic Focus on the U.S. MarketJanuary 28, 2025 | uk.finance.yahoo.comGlobus Medical raises FY24 revenue view to $2.52B from $2.49B-$2.5BJanuary 8, 2025 | markets.businessinsider.comGlobus Medical Stock: Re-Rated After A Solid YearNovember 18, 2024 | seekingalpha.comSee More Headlines NUVA Stock Analysis - Frequently Asked Questions How were NuVasive's earnings last quarter? NuVasive, Inc. (NASDAQ:NUVA) announced its quarterly earnings data on Wednesday, August, 2nd. The medical device company reported $0.56 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.56. The business's revenue for the quarter was up 2.4% on a year-over-year basis. Read the conference call transcript. Does NuVasive have any subsidiaries? NuVasive subsidiaries include these companies: Simplify Medical, SafePassage, Vertera Spine, Biotronic NeuroNetwork, Ellipse Technologies, NuVasive Clinical Services Monitoring Inc., NuVasive Japan KK, NuVasive Specialized Orthopedics Inc., and NuVasive Technology International Limited. What other stocks do shareholders of NuVasive own? Based on aggregate information from My MarketBeat watchlists, some other companies that NuVasive investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), First Solar (FSLR), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD). Company Calendar Last Earnings8/02/2023Today5/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:NUVA CIK1142596 Webwww.nuvasive.com Phone(858) 909-1800Fax800-475-9134Employees3,000Year Founded1997Profitability EPS (Most Recent Fiscal Year)$0.50 Trailing P/E Ratio79.50 Forward P/E Ratio17.91 P/E GrowthN/ANet Income$40.41 million Net Margins2.32% Pretax Margin3.41% Return on Equity12.17% Return on Assets4.88% Debt Debt-to-Equity Ratio0.50 Current Ratio1.25 Quick Ratio0.65 Sales & Book Value Annual Sales$1.23 billion Price / Sales1.70 Cash Flow$4.96 per share Price / Cash Flow8.01 Book Value$17.02 per share Price / Book2.34Miscellaneous Outstanding Shares52,449,000Free Float52,171,000Market Cap$2.08 billion OptionableOptionable Beta1.07 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:NUVA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuVasive, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NuVasive With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.